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Abstract
Sodium-coupled neutral amino acid transporter 2 (SNAT2) belongs to solute carrier 38
(SLC38) family of transporters, which is ubiquitously expressed in mammalian tissues and
mediates transport of small, neutral amino acids, exemplified by alanine(Ala, A). Yet struc-
tural data on SNAT2, including the relevance of intrinsic cysteine residues on structure and
function, is scarce, in spite of its essential roles in many tissues. To better define the poten-
tial of intrinsic cysteines to form disulfide bonds in SNAT2, mutagenesis experiments and
thiol-specific chemical modifications by N-ethylmaleimide (NEM) and methoxy-polyethylene
glycol maleimide (mPEG-Mal, MW 5000) were performed, with or without the reducing
regent dithiothreitol (DTT) treatment. Seven single mutant transporters with various cyste-
ine (Cys, C) to alanine (Ala, A) substitutions, and a C245,279A double mutant were intro-
duced to SNAT2 with a hemagglutinin (HA) tag at the C-terminus. The results showed that
the cells expressing C245A or C279A were labeled by one equivalent of mPEG-Mal in the
presence of DTT, while wild-type or all the other single Cys to Ala mutants were modified by
two equivalents of mPEG-Mal. Furthermore, the molecular weight of C245,279A was not
changed in the presence or absence of DTT treatment. The results suggest a disulfide bond
between Cys245 and Cys279 in SNAT2 which has no effect on cell surface trafficking, as
well as transporter function. The proposed disulfide bond may be important to delineate
proximity in the extracellular domain of SNAT2 and related proteins.
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Introduction
The SLC38 family of transporters represents a main branch of solute carrier families in mam-
mals [1]. Most of the 11 transporters in this family are Na+-dependent and are able to carry out
net transport of neutral amino acids except 5 orphan transporters [2]. The other six of these
family members have been well-characterized to date and have been subdivided into System A
(SNAT1, SNAT2 and SNAT4) [3–6].and System N (SNAT3, SNAT5 and SNAT7) [7–11]
transporters, in terms of their functional properties and patterns of regulation. System A pre-
fers small aliphatic amino acids, while System N has a much narrower substrate profiles of glu-
tamine, asparagine and histidine [12, 13]. In addition, System N has the ability to co-transport
Na+ and antiport H+ [5,14]. However, System A transports substrates coupled to the uptake of
Na+ with a stoichiometry of 1:1 [15].
Sodium-coupled neutral amino acid transporter 2 (SNAT2, previously ATA2, SA1, or
SAT2) is a prototype for System A which has a very broad tissue distribution profile [16–22].
SNAT2 mediates transportation of a broad range of zwitterionic, aliphatic amino acids, such as
alanine, asparagine, cysteine, glutamine, glycine, histidine, methionine, proline, and serine.
SNAT2 operates by a mechanism with ordered binding (Na+ first) and 1 Na+: 1 amino acid
coupling stoichiometry. It has been reported that SNAT2 is assigned many important physio-
logical roles. SNAT2 has been suggested to be involved in glutamine transport in the gluta-
mate/glutamine cycle in neurons with some other members of SLC38 family [13, 23–26]. In
the liver, SNAT2 plays a significant role in the gluconeogenesis and ammonia detoxification
from portal blood [27, 28]. The increasing expression of SNAT2 in hypertonically stressed cells
indicates the role of SNAT2 in the cell volume regulation [29–31]. Furthermore, SNAT2
appears to play a role in cell growth and differentiation by signaling through the mTOR path-
way [32, 33]. There is evidence that SNAT2 is up-regulated in cancer, for instance, human liver
cancer and prostate cancer [34].
In contrast to our broad knowledge of SNAT2’s functional roles, there is relatively little
known about its structure. SNAT2 contains 504 amino acids residues with a predicted molecu-
lar mass of 56 kDa. Hydropathy plotting indicates that SNAT2 has 11 transmembrane helices
(TM) with an intracellular N terminus and an extracellular C terminus [1, 20]. Homology
models of SNAT2 based on the structure of LeuTAa/Mhp1 show a tandem duplication between
segments containing TM 1–5 and TM 6–10 [35]. Previously, we have shown that Histidine
(His) 304 is required for the transport of Ala [36]. Asparagine (Asn) 82 in TM1 and Threonine
(Thr) 384 in TM8 are proposed to form a possible Na+ binding site [35, 37]. Furthermore, a
large portion of the C-terminus of SNAT2 plays a significant role for amino acid translocation
and its voltage dependence [38]. The highly conserved C-terminus His504 is reported to be
related to the pH-sensitivity of SNAT2 [39].
Disulfide bridges between correct pairs of cysteine residues are crucial to the trafficking [40],
stability [41, 42] and function [43–46] of transmembrane proteins. A recent study has shown
that the disulfide bond formed by Cys249 and Cys321 plays an essential role in the substrate
transport of SNAT4 [47], another member of System A, which shares 57% sequence homology
with SNAT2. Better understanding of potential disulfide bridge formation of SNAT2 is vital to
the delineation of its transport mechanism. Because of the limited expression and purification of
SNAT2 protein, it is difficult to use conventional methods that are only feasible with proteins in
abundant quantities, such as crystallization and NMR. In this study, therefore, we employed a
combination of mutagenesis and thiol-specific chemical modifications by N-ethylmaleimide
(NEM) and methoxy-polyethylene glycol maleimide (mPEG-Mal, MW 5000).
Here, we first prepared extracts from HEK 293T cells that express wild-type SNAT2 and
performed thiol-specific chemical modification by sequential treatment with NEM, DTT, and
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mPEG-Mal under denatured condition. After assessing the influence of DTT on the molecular
weight of the wild-type transporter, systematic mutagenesis was performed with various single
Cys replaced with Ala, and these mutant transporters were modified with the same method as
wild-type SNAT2. Immunofluorescence methods were used to detect the expression levels and
localization of the mutants. The result suggested that a disulfide bridge is formed between
Cys245 and Cys279 which, however, has little effect on the trafficking to cell surface of SNAT2,
as well as transport function of SNAT2.
Materials and Methods
Materials
PEG-Mal was purchased from Laysan Bio. NEM was from Sigma. DTT was bought from
Biosharp. Oligonucleotide primers were synthetized by SanGon. La Taq DNA polymerase
was from TaKaRa. Human Embryo Kidney cells (HEK293T, ATCC number CRL 11268)
were purchased from the Typical Culture Collection cell bank, Chinese Academy of Sciences.
Dulbecco’s modified Eagle’s medium (DMEM) was bought from Gibco. Lipofectamine 2000
transfection reagent and Alexa Fluor 568 donkey anti-mouse IgG secondary antibody were
purchased in Invitrogen. PVDF membrane and Chemiluminescence HRP Substrate were
acquired from Millipore. Anti-HA tag mouse monoclonal antibody and Anti-GAPDHmouse
monoclonal antibody were purchased from ImB. HRP-linked goat anti-mouse IgG secondary
antibody and protein inhibitors were bought from Sigma. Polaroid films were bought from
Kodak.
Site-directed mutagenesis of SNAT2
Mutants of SNAT2 were constructed using the rat SNAT2 with an HA tag at the C-terminus in
a eukaryotic expression vector pBK-CMVΔ(1098–1300) (pBK-CMVΔ-SNAT2- HA). Point
mutations were introduced using the primers listed in Table 1. Cysteine residues at position
228, 238, 245, 279, 303, 401, and 475 were mutated to alanine or serine, respectively. Double
mutation was generated by mutating both Cys245 and Cys279 to alanine or serine. In all
mutants, introduction of the correct mutation were confirmed by DNA sequencing.
Table 1. DNA primers used for site-directed mutagenesis.
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Cell culture and transfection
HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM), supplemented
with 10% FBS, 4 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin at 37°C in
a humidified incubator under an atmosphere of 5% CO2 in air. After plating the cells on
35-mm dishes for 24 h, plasmids of either pBK-CMVΔ-SNAT2-HA wild type or mutant trans-
porter were transiently transfected into cells respectively using Lipofectamine 2000 according
to the manufacturer’s protocol.
Extraction of cell total proteins
After transfection for 24 h, HEK293T cells were washed 2–3 times with ice-cold PBS contain-
ing 0.1 mM CaCl2, 1mMMgCl2 and then lysed in RIPA lysis buffer containing 100 mM Tris-
Cl (pH 7.4), 150 mMNaCl, 1mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS and protease inhibitor. Freeze-thawing technique was used to break the cells. The intact
cells and nucleus were removed by centrifugation at 1000 g for 15 min at 4°C. The supernatant
was removed and represents the total protein fraction. Protein concentrations were determined
with BCA protein assay kit according to the manufacturer’s instruction.
Immunofluorescence microscopy
Immunofluorescence staining was performed on transiently transfected HEK293T cells grown
on glass coverslips in 35-mm dishes 24 h after transfection. Cells were washed with phosphate-
buffered saline (PBS) for 3 times, and then fixed with 4% paraformaldehyde in PBS for 30 min.
After washed twice with PBS to remove the excess of paraformaldehyde, the cells were incu-
bated with 1% bovine serum albumin (BSA) in PBS to block the nonspecific binding. Cells
were then incubated with anti-HA tag mouse monoclonal antibody (1:1000 dilution) and
Alexa Fluor 568 donkey anti-mouse IgG (1:500 dilution) in the dark for 2 h in sequence. Nuclei
were stained with 4,6-diamidino-2-phenylindole dihydrochloride (DAPI; 1:1000 dilution). All
steps were performed at room temperature. Images were obtained by using a Leica TCS SP5
confocal laser-scanning microscope.
Protein modification with NEM and mPEG-Mal
NEM, DTT, and mPEG-Mal solution were freshly prepared in lysate buffer (10% SDS, 1 mM
EDTA, 50 mM Tris-HCl, pH 7.5). After transfection for 24 h, HEK293T cells cultured in
3.5mm dishes were washed 2–3 times with PBS and scraped into 100 μL of lysate buffer supple-
mented with 50mMNEM or DTT. The modification reaction was carried out for 30 min.
Excess NEM or DTT in the lysate were removed by chloroform/methanol precipitation method
with methanol/chloroform/water (4:1:3 V/V/V) treatment in order. Subsequently, the experi-
mental group and control group pellets were respectively dissolved in the lysate buffer with or
without 50 mMDTT or 50 mMNEM, and then incubated for 30 min. After precipitated by
methanol/chloroform/water as described above, the proteins were dissolved in the lysate Buffer
containing 8 mMmPEG-Mal and incubated for 30 min. All these modification steps were per-
formed at room temperature.
SDS-PAGE andWestern blotting
Cell lysates and modified proteins were fractionated by 8% SDS-PAGE and electrotransferred
onto a PVDF membrane. Nonspecific binding was blocked with TBST containing 0.1% Tween
20 and 5% skim milk. The membrane was then incubated for 3 h with the primary antibody
(anti-HA tag and anti-GAPDHmouse monoclonal antibody) diluted 1:3000 in 2.5% skim milk
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in TBST. The secondary antibody (HRP-conjugated goat anti-mouse IgG antibody) was used
in a dilution of 1:10000 in 2.5% skim milk in TBST for 1 h at room temperature. Bands were
visualized using an enhanced chemiluminescence detection method with ECLWestern blotting
detection kit. The bands are smeared because there are two predicted glycosylation sites in the
SNAT2.
Amino acid uptake assay
HEK293T cells were plated on collagen-coated 12-well plates (1×105/well) in DMEM (contain-
ing 10% fetal bovine serum, 100 units/mL of penicillin, 10 μg/mL of streptomycin, and 4 mM
of glutamine. 48h after transfection with vector, wild-type SNAT2, or SNAT2 serine mutants
cDNA, the cells were washed with uptake buffer (containing 140 mM sodium methaneuslfo-
nate, 2 mMmagnesium methanesulfonate, 2 mM calcium gluconate, 30 mM Tris-Mes, pH 8.0,
5 mM glucose) 2 times. The cells were preincubated in the same buffer for 5 min at 37°C, then
the buffer was removed and replaced with fresh buffer containing unlabeled α-methyl-amino-
isobutyric acid (MeAIB) and 0.4 μCi of [14C] MeAIB (PerkinElmer Life Sciences; total concen-
tration 40 μM). Uptake was terminated by washing twice with 1 mL of uptake buffer on ice
after 1 min of incubation at room temperature. The cells were then solubilized in 0.5 mL of 1%
SDS, and radioactivity was measured by scintillation couting in 3 ml of scintillation fluid. The
MeAIB uptake measurements were performed in triplicate.
Whole-cell current recording
HEK293T cells cultures were transiently transfected with wild-type or mutant cDNA. One day
after transfection, the cells were used for electrophysiological measurements. Alanine-induced
SNAT2 currents were recorded in the whole-cell current recording configuration. Whole-cell
currents were recorded with an EPC7 patch clamp amplifier (ALA Scentific, Westbury, NY) at
steady state. The resistance of the recording was 2–3 megohms, as described previously [35–37].
Statistical analysis
Data shown are presented as the mean ± standard deviation (SD). Differences between 2
groups were examined for statistical significance using the Student’s t-test. When more than
two groups were compared, analysis of Variance (ANOVA) is used to determine statistical
significance.
Results
Identifying a disulfide bridge in wild-type SNAT2-HA
In order to identify the existence of potential disulfide bridges in SNAT2, a chemical modifica-
tion approach was performed utilizing wild-type SNAT2-HA with or without the reducing
reagent DTT. Thiol-specific reagents NEM and mPEG-Mal were employed, both of which can
only react with free sulfhydryls in proteins. NEM has a small molecular weight of 125 Da,
which has little effect on the mobility of covalent binding proteins in polyacrylamide gels, as
detected byWestern blotting analysis. In comparison, modification by mPEG-Mal can be easily
detected on SDS-PAGE. By virtue of the hydrodynamic properties of mPEG-Mal, the PEG
adducts run with a slower mobility on SDS-PAGE. Adding one PEG molecule will increase the
apparent molecular mass of the parent protein by 10*15 kDa, in spite of the fact that PEG car-
bohydrate moiety is only 5 kDa. As can be seen in Fig 1A (lane 2), after modification by NEM,
the migration rate of the modified wild-type SNAT2-HA was consistent with that of the
unmodified SNAT2-HA on SDS-PAGE. After blocking all of the free thiols with NEM and
Disulfide Bridge in SNAT2
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followed by DTT treatment under denaturing conditions, a SNAT2-HA band with a larger
molecular mass of about 110 kDa could be observed (Fig 1A, lane 3), suggesting that cysteine
residues of SNAT2 may be engaged in disulfide bridges. In contrast, when the wild-type
SNAT2-HA was treated with DTT firstly, and subsequently modified by NEM, followed by
PEG, the migration rate was consistent with that of unmodified SNAT2-HA (Fig 1B, lane 1
and 2). These results indicate that SNAT2 HA can be modified by PEG when thiols forming a
potential disulfide bridge are reduced through DTT treatment, but only before they are blocked
from PEG modification by NEM.
Residues Cys245 and Cys279 are linked by a disulfide bridge
To identify the cysteine residues involved in the formation of the disulfide bond, single mutants
were constructed by substituting each of the seven cysteine residues in SNAT2-HA with ala-
nine. All of these mutant transporters were modified sequentially by NEM and mPEG-Mal, in
the presence or absence of DTT.
For the mutant transporters C228A, C238A, C303A, C401A, and C475A, the protein appar-
ent molecular weight was shifted from 55~70 kDa in the absence of DTT (Fig 2, lane 3, 5, 11,
13, and 15) to 110 kDa after DTT treatment (Fig 2, lane 4, 6, 12, 14, and 16), consistent with
Fig 1. Western blotting analysis of wild-type SNAT2-HAmodified by NEM andmPEG-Mal. Lysates of HEK293T cells expressing wild-type SNAT2-HA
were processed by sequential treatment of NEM, DTT, and mPEG-Mal (A) or DTT, NEM, and mPEG-Mal (B) under denatured condition. Controls were
treated without DTT. The proteins were separated on an 8% SDS gel, detected by immunodetection with the mouse anti-HA tag antibody followed by the
HRP-conjugated goat anti-mouse secondary antibody. Anti-GAPDHmouse monoclonal antibody was used to detect the GAPDH as an internal reference.
doi:10.1371/journal.pone.0158319.g001
Disulfide Bridge in SNAT2
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that of the wild-type transporter (Fig 2, lane 1 and 2). The result indicated the existence of
disulfide bond in these mutant transporters, which means residues Cys 228, 238, 303, 401, and
475 did not participate in the formation of disulfide bond of SNAT2.
In contrast, for mutants C245A and C279A, the protein molecular mass without DTT treat-
ment was 55~70 kDa (Fig 2, lane 7 and 9), while it was 55–80 kDa in the presence of DTT (Fig
2, lane 8 and 10). If only one instead of two cysteines can be modified by mPEG-Mal, due to
the single mutation, a lower MW increase compared to SNAT2-HAWT is expected. Further-
more, the molecular mass of the C245,279A double mutant transporter, with or without DTT
treatment, was 55~70 kDa (Fig 3, lane 7 and 8), equal to that of the wild-type in the absence of
DTT. These results suggested the absence of disulfide bridges in this double mutant trans-
porter, providing further evidence for a disulfide bridge between Cys245 and Cys279. Together,
these results suggest that residues Cys245 and Cys279 are linked by a disulfide bond in the
SNAT2 transporter protein.
Expression and localization of wild-type and mutant SNAT2-HA
To confirm cell expression of Cys to Ala mutants of SNAT2-HA, HEK293T cells were tran-
siently transfected with plasmids encoding SNAT2-HA mutants and wild-type as a positive
control. As can be seen in Fig 4, the molecular weight of all these mutant transporters were
about 55~70 kDa, consistent with that of the wild-type protein. The images obtained from
immunofluorenscence staining (Fig 5) showed all the SNAT2-HA mutants are localized at the
surface of the cell, which means the disruption of the proposed disulfide bond does not affect
trafficking of SNAT2 to the cell surface.
Fig 2. Western blotting analysis of SNAT2-HA wild-type and 7 single cysteinemutants modified by NEM andmPEG-Mal implicates Cys245 and
Cys279 in a disulfide bridge. Lysates of HEK293T cells expressing either wild-type or 7 single cysteine mutants were processed by sequential treatment
of NEM, DTT, and mPEG-Mal under denatured condition. Controls were treated without DTT. The proteins were separated on an 8% SDS gel, detected by
immunodetection with the mouse anti-HA tag antibody followed by the HRP-conjugated goat anti-mouse secondary antibody. Anti-GAPDHmouse
monoclonal antibody was used to detect the GAPDH as an internal reference.
doi:10.1371/journal.pone.0158319.g002
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Contribution of Cys residues and the disulfide bond to SNAT2 transport
function
The contribution of each Cys residue to SNAT2 transport activity was investigated by measur-
ing MeAIB uptake experiments, transport currents induced by 10mM Ala and Km for Ala,
respectively. In order to reduce the effect of amino acid substitution on transport function of
SNAT2, Cysteine residues at position 228, 238, 245, 279, 303, 401, and 475 were mutated to
serine, respectively. The double mutation was generated by mutating both Cys245 and Cys279
to serine. Single mutant C228S or C303S reduced around 75% of the MeAIB uptake of SNAT2,
demonstrated that both of C228 and C303 are important to transport function of SNAT2 (Fig
6A). Although C245S or C279S reduced the MeAIB uptake of SNAT2, the results were not
significantly different compared with SNAT2WT. (The single mutant of C245S and C279S
retained 88% and 65% of MeAIB uptake of SNAT2WT, respectively). The MeAIB uptake of
double mutant of C245SC279S retained about 62% of that of SNAT2, almost was the same as
Fig 3. Western blotting analysis of SNAT2-HA wild-type andmutants C245A, C279A, C245,279Amodified by NEM and
mPEG-Mal. Lysates of HEK293T cells expressing either wild-type or mutant transporters, C245A, C279A, C245,279A were
processed by sequential treatment of NEM, DTT, and mPEG-Mal under denatured condition. Controls were treated without DTT. The
proteins were separated on an 8% SDS gel, detected by immunodetection with the mouse anti-HA tag antibody followed by the HRP-
conjugated goat anti-mouse secondary antibody. Anti-GAPDHmouse monoclonal antibody was used to detect the GAPDH as an
internal reference.
doi:10.1371/journal.pone.0158319.g003
Disulfide Bridge in SNAT2
PLOSONE | DOI:10.1371/journal.pone.0158319 June 29, 2016 8 / 16
C279S, appeared to be slightly reduced by the double mutation. Application of 10 mM alanine
to SNAT2WT- and mutants-expression cells resulted in inwardly directed transport currents at
0 mV membrane potential (data not shown), average current of 106±12 pA for SNAT2WT.
Except C405S, transport currents induced by 10 mM Ala of other mutants were decreased sig-
nificantly compare to SNATWT, but at least about 35% or above were retained (Fig 6B). C245S
(39±3 pA) and C279S (37±6 pA) retained 37% and 35% of transport current compare to
SNATWT, respectively, while C245SC279S retained about 40% of transport current (44±2 pA),
showed slight increased by double mutants. The apparent affinity of SNAT2WT to alanien was
200±18 μM, C228S (289±56 μM, C238S (485±48 μM, C401S (415±37 μM) and C475S (401
±49 μM) increased it 1~2 fold, showed that these four cysteines didn’t contribute too much to
the alanine binding to SNAT2 (Fig 6C). While C303S increased the apparent affinity 8~9 fold
(1833±475 μM), indicated C303 probably involved in binding Ala to SNAT2. The affinity abil-
ity to alanine of both C245S and C279S decreased 3~4 fold (Km 689±60 μM for C245S and Km
777±80 μM for C279) compared to SNAT2WT, respectively, double mutant’s Km (634±44 μM)
was the same as single mutants. All these results showed that the disulfide bridge formed
between C245 and C279 is not absolutely required for the transport function of SNAT2, some
Cysteines in SNAT2, such as C228 and C303, probably play an important role in the function
of SNAT2 transport.
Discussion
Disulfide bridges have been shown to play roles in various transmembrane proteins. However,
the potential formation of a disulfide bridge in SNAT2 has never been investigated. In this
study, we performed chemical modification with thiol-specific reagents, such as NEM and
Fig 4. Western blotting analysis of SNAT2-HA wild-type and Cys to Ala mutants in cell total proteins. Lysates of HEK293T cells expressing either
wild-type or mutant transporter were separated on an 8% SDS gel, detected by immunodetection with the mouse anti-HA tag antibody followed by the
HRP-conjugated goat anti-mouse secondary antibody. Anti-GAPDHmouse monoclonal antibody was used to detect the GAPDH as an internal reference.
doi:10.1371/journal.pone.0158319.g004
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Fig 5. Immunofluorescence staining of SNAT2-HA wild-type and Cys to Ala mutants indicates correct
membrane targeting of these transporters.HEK293T were transiently transfected with wild-type or mutant
SNAT2-HA. 24 h after transfection, cells were incubated with the primary mouse anti-HA tag antibody
followed by the secondary donkey anti-mouse Alexa Fluor 568 antibody. Nuclei were stained with DAPI.
Scale bar = 25 μm.
doi:10.1371/journal.pone.0158319.g005
Fig 6. Transport function of Cys residues and the disulfide bond in SNAT2. A, MeAIB uptake of SNAT2 wild-type and Cys to Ser mutants. HEK293T
were transiently transfected with wild-type or mutant SNAT2. Transport of [14C] MeAIB (40μM) was measured at 1 min in NaMes-containing buffer. The
uptake of the vector was subtracted. B, average transport currents induced by the application of 10 mM alaine to SNAT2WT- and Cys to Ser mutants-
expression cells. The currents of non-transfected cells were subtracted. C, the apparent affinities for the substrate L-alanine of SNAT2WT and Cys to Ser
mutant. Km, Michaelis constant. The black stars (*) indicate statistical significance compared with SNAT2WT (***P < 0.001, * P < 0.05). The pound (#)
indicates statistical significance compared with C245SC279S at the P <0.05 level. Values are means ± S.D. for at least three independent experiments.
doi:10.1371/journal.pone.0158319.g006
Disulfide Bridge in SNAT2
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mPEG-Mal, providing the first evidence for disulfide bridging in SNAT2, and identifying C245
and C279 as candidates for forming the bridge.
mPEG-Mal is a membrane-impermeant reagent and has been shown to be a useful tool to
study the topology of membrane proteins [43, 48–50]. This method has been used successfully
to identify the disulfide bonds in transmembrane proteins, for example, acyl-coenzyme A:cho-
lesterol acyltransferase 1 (ACAT1) [49] and the yeast vacuolar ATPase (V-ATPase) [50]. The
double bond of maleimide in both NEM and mPEG-Mal can readily react with the thiol group
of free cysteine, to form a stable carbon-sulfur bond [51]. NEM is commonly used as alkylating
reagent of cysteine residues. Cys residues in putative transmembrane domains are inaccessible
to NEM under native condition [52], while form covalent bonds with NEM under denatured
condition [53]. The molecular weight of NEM is 125 Da, which renders modification of large
proteins undetectable on SDS-PAGE. In contrast, mPEG-Mal has a large molecular mass of 5
kDa. For each thiol group, mPEG-Mal adds a PEG molecule, and the protein’s apparent molec-
ular weight can be increased by more than 10–15 kDa, which can be easily detected by Western
blotting analysis [48].
In our present study, the wild-type and single Cys to Ala mutants C228A, C238A, C303A,
C401A, and C475A of SNAT2-HA could be modified by two equivalents of PEG after DTT
treatment, while C245A and C279A could bind only one PEG molecule per transporters unit.
The most likely reason is that when one cysteine forming the disulfide bridge is mutated, the
opposite cysteine may be blocked by some thiol-containing small molecules such as GSH,
which made it couldn’t be modified by NEM. When the covalent compound was disrupted by
DTT, the exposed thiol would be able to react with mPEG-Mal. In C245,279A double mutant,
no PEG molecules could be attached after DTT treatment, which provided further evidence
that Cys245 and Cys279 are linked by a disulfide bond. Together, these results support a
disulfide bridge formed between Cys245 and Cys279 in the third extracellular loop, as shown
in Fig 7.
There are 7 cysteine residues in SNAT2, four of which are highly conserved across the
SLC38 family transporters. These residues are Cys228, Cys245, Cys279, and Cys303. As can be
seen in the topology structure in Fig 7, Cys228 and Cys303 are respectively located in TM5 and
TM6, while Cys245 and Cys279 are present on the third extracellular loop. Interestingly, a
recent study showed that the conserved cysteine residues Cys249 and Cys321 in SNAT4 [47],
which reside in the position corresponding to Cys245 and Cys279 of SNAT2, were linked by a
disulfide bond. SNAT4 is another subtype of System A, which shares 57% sequence homology
with SNAT2. The disulfide bond forming-cysteines of both SNAT2 and SNAT4 are present on
the large extracellular loop, which may be a conserved structure symbol of SNAT family mem-
bers. This has also been found in GABA and glutamate transporters [54, 55], and may suggest
a general structural feature among these transporters of different families.
Homology models of the SNAT2 structure have been proposed [35, 56], based on the LeuT
folds as a template. However, the structure of the extracellular loops cannot be modeled based
on these structures. Therefore, the proposed disulfide linkage can provide important con-
straints for future modeling of the large extracellular loop between predicted TMs 5 and 6.
Disulfide bridges have been reported to play vital roles in the trafficking to the cell surface
of protein. In CD36, the formation of disulfide bonds is required for protein transportation
from the endoplasmic reticulum to Golgi [57]. A disulfide bond in the dopamine transporter is
necessary for its delivery to the cell surface, while not essential for the uptake function. For the
ATP-binding cassette (ABC) transporter ABCB6 and sulfonylurea receptor 1 (SUR1)/ABCC8,
the breaking of disulfide bonds is closely related to protein degeneration [58]. Study of hPAT1
shows a dramatic effect on its transport function when the disulfide bond is disrupted [43]. Sin-
gle cysteine residues are also found to be important for the structural integrity and transport
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function in proteins such as many GPCRs and some transporters [45, 46, 59–61]. However, we
found that the disulfide bridge in SNAT2 is not essential for its trafficking to the plasma mem-
brane (Fig 5), which is also observed in SNAT4 and hPAT1 [47, 60]. We also studied the effect
of cysteines and the disulfide bridge on SNAT2 transport function by measuring MeAIB
uptake, transport current at 10 mM alanine and apparent affinity to alanine (Fig 6). The highly
conserved C228 and C303 are very important to transport function compared with SNAT2WT.
The single mutant of C245S, C279S mutation did not significantly impair the transport activity
of SNAT2WT. The double mutant transporter showed reduced MeAIB uptake, increased trans-
port current at 10 mM alanine, and similar to apparent affinity, compare to single mutant of
C245S, C279S mutation. but could still retain transport activity. This result indicates that the
disulfide bond in SNAT2, while having some impact on transport, is not required for the trans-
port function.
Recent studies have shown that SNAT2 does not only function as a transporter, but also
function as a hybrid transporter-receptor (transceptor). As a member of system A transporters,
SNAT2 carries out net transport of amino acids, therefore modulates the mTOR pathway
through regulating intracellular amino acid concentration [32]. As a transceptor, SNAT2 can
sense extracellular amino acid concentration and activate intracellular downstream signaling
pathways such as mTOR, GCN, PI3K and CXCR4 pathways [35, 62–64]. The disulfide bridge
in SNAT2 may play essential roles in signal transduction through thiol-disulfide exchange
reactions, which remains to be shown [65].
In conclusion, a disulfide bridge between Cys245 and Cys279 in SNAT2 was identified in
this paper, and our current results will be a foundation for the future study of SNAT2 and
Fig 7. Topological model of SNAT2. The locations of 7 cysteine residues are indicated (arrows) in the proposed structure of SNAT2. The
disulfide bond is shown as a dashed line.
doi:10.1371/journal.pone.0158319.g007
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other members of SLC38 family, providing constraints for the structural fold for the important
extracellular loop between TMs 5 and 6.
Author Contributions
Conceived and designed the experiments: ZZ ZYG CG. Performed the experiments: CC JHW
RPC YMY. Analyzed the data: CC JHW ZZ. Contributed reagents/materials/analysis tools: CC
JHW. Wrote the paper: CC ZZ CG.
References
1. Schiöth HB, Roshanbin S, Hägglund MG, Fredriksson R. Evolutionary origin of amino acid transporter
families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects. Mol
Aspects Med. 2013; 34: 571–585. doi: 10.1016/j.mam.2012.07.012 PMID: 23506890
2. Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N/A) transporters of the
SLC38 gene family. Pflügers Archiv, 2004; 447: 784–795. PMID: 12845534
3. Oxender DL, Christensen HN. Distinct mediating systems for the transport of neutral amino acids by
the Ehrlich cell. J Biol Chem. 1963; 238: 3686–3699. PMID: 14109206
4. Reimer RJ, Chaudhry FA, Gray AT, Edwards RH. Amino acid transport system A resembles systemN in
sequence but differs in mechanism, Proc Natl Acad Sci U S A. 2000; 97: 7715–7720. PMID: 10859363
5. Varoqui H, Zhu H, Yao D, Ming H, Erickson JD. Cloning and functional identification of a neuronal gluta-
mine transporter. J Biol Chem. 2000; 275: 4049–4054. PMID: 10660562
6. Sugawara M, Nakanishi T, Fei YJ, Martindale RG, Ganapathy ME, Leibach FH, et al. Structure and
function of ATA3, a new subtype of amino acid transport system A, primarily expressed in the liverand
skeletal muscle. Biochim Biophys Acta. 2000; 1509: 7–13. PMID: 11118514
7. Kilberg MS, Handlogten ME, Christensen HN. Characteristics of an amino acid transport system in rat
liver for glutamine, asparagine, histidine, and closely related analogs. J Biol Chem. 1980; 255: 4011–
4019. PMID: 7372663
8. Fei YJ, Sugawara M, Nakanishi T, HuangW, Wang H, Prasad PD, et al. Primary structure, genomic
organization, and functional and electrogenic characteristics of human system N1, a Na+- and H+-cou-
pled glutamine transporter. J Biol Chem. 2000; 275: 23707–23017. PMID: 10823827
9. Nakanishi T, Kekuda R, Fei YJ, Hatanaka T, Sugawara M, Martindale RG, et al. Cloning and functional
characterization of a new subtype of the amino acid transport system N. Am J Physiol Cell Physiol.
2001; 281: 1757–1768.
10. Nakanishi T, Sugawara M, HuangW, Martindale RG, Leibach FH, Ganapathy ME, et al. Structure, func-
tion, and tissue expression pattern of human SN2, a subtype of the amino acid transport system N. Bio-
chem Biophys Res Commun. 2001; 281: 1343–1348. PMID: 11243884
11. Hägglund MG, Sreedharan S, Nilsson VC, Shaik JH, Almkvist IM, Bäcklin S, et al. Identification of
SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011; 286:
20500–20511. doi: 10.1074/jbc.M110.162404 PMID: 21511949
12. Barker GA, Ellory JC. The identification of neutral amino acid transport systems. Exp Physiol 1990; 75:
3–26. PMID: 2178639
13. Chaudhry FA, Reimer RJ, Edwards RH. The glutamine commute: take the N line and transfer to the A.
J Cell Biol. 2002; 157: 349–355. PMID: 11980913
14. Gu S, Roderick HL, Camacho P, Jiang JX. Characterization of an N-system amino acid transporter
expressed in retina and its involvement in glutamine transport. J Biol Chem. 2001; 276: 24137–24144.
PMID: 11325958
15. Mackenzie B, Schäfer MK, Erickson JD, Hediger MA, Weihe E, Varoqui H. Functional properties and
cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central
neurons. J Biol Chem. 2003; 278: 23720–23730. PMID: 12684517
16. Johnson LW, Smith CH. Neutral amino acid transport systems of microvillous membrane of human pla-
centa. Am J Physiol. 1988; 254: C773–780. PMID: 3377068
17. Hatanaka T, HuangW, Wang H, Sugawara M, Prasad PD, Leibach FH, et al. Primary structure, func-
tional characteristics and tissue expression pattern of human ATA2, a subtype of aminoacid transport
system A. Biochim Biophys Acta. 2000; 1467: 1–6. PMID: 10930503
18. Sugawara M, Nakanishi T, Fei YJ, HuangW, Ganapathy ME, Leibach FH, et al. Cloning of an amino
acid transporter with functional characteristics and tissue expression pattern identical to that of system
A J Biol Chem. 2000; 275: 16473–16477. PMID: 10747860
Disulfide Bridge in SNAT2
PLOSONE | DOI:10.1371/journal.pone.0158319 June 29, 2016 13 / 16
19. Bode BP. Recent molecular advances in mammalian glutamine transport. The Journal of nutrition.
2001; 131: 2475S–2485S. PMID: 11533296
20. Yao D, Mackenzie B, Ming H, Varoqui H, Zhu H, Hediger MA, et al. A novel system A isoformmediating
Na+/neutral amino acid cotransport, J Biol Chem. 2000; 75: 22790–22797.
21. Sundberg BE, Waag E, Jacobsson JA, Stephansson O, Rumaks J, Svirskis S, et al. The evolutionary
history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32,
SLC36, and SLC38. J Mol Neurosci. 2008; 35: 179–193. doi: 10.1007/s12031-008-9046-x PMID:
18418736
22. Chaudhry FA, Schmitz D, Reimer RJ, Larsson P, Gray AT, Nicoll R, et al. Glutamine uptake by neurons:
interaction of protons with system A transporters. J Neurosci. 2002; 22: 62–72. PMID: 11756489
23. Conti F, Melone M. The glutamine commute: lost in the tube, Neurochem. Int. 2006; 48: 459–464.
PMID: 16517023
24. Gammelsaeter R, Jenstad M, Bredahl MK, Gundersen V, Chaudhry FA. Complementary expression of
SN1 and SAT2 in the islets of Langerhans suggests concerted action of glutamine transport in the regu-
lation of insulin secretion. Biochem Biophys Res Commun. 2009; 381: 378–382. doi: 10.1016/j.bbrc.
2009.02.062 PMID: 19233140
25. Jenstad M, Quazi AZ, Zilberter M, Haglerød C, Berghuis P, Saddique N, et al. System A transporter
SNAT2 mediates replenishment of dendritic glutamate pools controlling retrograde signaling by gluta-
mate. Cereb Cortex. 2009; 19: 1092–1106. doi: 10.1093/cercor/bhn151 PMID: 18832333
26. Blot A, Billups D, Bjørkmo M, Quazi AZ, Uwechue NM, Chaudhry FA, et al. Functional expression of
two system A glutamine transporter isoforms in rat auditory brainstem neurons. Neuroscience. 2009;
164: 998–1008. doi: 10.1016/j.neuroscience.2009.09.015 PMID: 19751803
27. Varoqui H, Erickson JD. Selective up-regulation of system a transporter mRNA in diabetic liver. Bio-
chem Biophys Res Commun. 2002; 290: 903–908. PMID: 11798158
28. Ortiz V, Alemán G, Escamilla-Del-Arenal M, Recillas-Targa F, Torres N, Tovar AR. Promoter character-
ization and role of CRE in the basal transcription of the rat SNAT2 gene. Am J Physiol Endocrinol
Metab. 2011; 300: E1092–1102. doi: 10.1152/ajpendo.00459.2010 PMID: 21386061
29. Franchi-Gazzola R, Gaccioli F, Bevilacqua E, Visigalli R, Dall'Asta V, Sala R, et al. The synthesis of
SNAT2 transporters is required for the hypertonic stimulation of system A transport activity. Biochim
Biophys Acta. 2004; 1667: 157–166. PMID: 15581851
30. Bevilacqua E, Bussolati O, Dall'Asta V, Gaccioli F, Sala R, Gazzola GC, et al. SNAT2 silencing pre-
vents the osmotic induction of transport system A and hinders cell recovery from hypertonicstress.
FEBS Lett. 2005; 579: 3376–3380. PMID: 15922329
31. Franchi-Gazzola R, Dall'Asta V. Sala R, Visigalli R, Bevilacqua E, Gaccioli F et al. The role of the neu-
tral amino acid transporter SNAT2 in cell volume regulation. Acta physiologica. 2006; 187: 273–283.
PMID: 16734764
32. Evans K, Nasim Z, Brown J, Butler H, Kauser S, Varoqui H, et al. Bevington A Acidosis-sensing gluta-
mine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to pro-
tein synthesis in L6 muscle cells. Journal of the American Society of Nephrology. 2007; 18: 1426–1436.
PMID: 17429052
33. Pinilla J, Aledo JC, Cwiklinski E, Hyde R, Taylor PM, Hundal HS. SNAT2 transceptor signalling via
mTOR: a role in cell growth and proliferation. Front Biosci (Elite Ed). 2011; 3: 1289–1299.
34. Okudaira H, Shikano N, Nishii R, Miyagi T, Yoshimoto M, Kobayashi M, et al. Putative transport mecha-
nism and intracellular fate of trans-1-amino-3-18F -fluorocyclobutanecarboxylic acid in human prostate
cancer. J Nucl Med. 2011; 52: 822–829. doi: 10.2967/jnumed.110.086074 PMID: 21536930
35. Zhang Z, Albers T, Fiumera HL, Gameiro A, Grewer C. A conserved Na+ binding site of the sodium-cou-
pled neutral amino acid transporter 2 (SNAT2). J Biol Chem. 2009; 284: 25314–25323. doi: 10.1074/
jbc.M109.038422 PMID: 19589777
36. Zhang Z, Grewer C. The sodium-coupled neutral amino acid transporter SNAT2mediates an anion
leak conductance that is differentially inhibited by transported substrates. Biophysical journal. 2007; 2:
2621–2632.
37. Zhang Z, Gameiro A, Grewer C. Highly conserved asparagine 82 controls the interaction of Na+ with
the sodium-coupled neutral amino acidtransporter SNAT2. J Biol Chem. 2008, 283: 12284–12292. doi:
10.1074/jbc.M706774200 PMID: 18319257
38. Zhang Z, Zander C, Grewer C. The C-terminal domain of the neutral amino acid transporter SNAT2 reg-
ulates transport activity through voltage-dependent processes.Biochem J. 2011; 434: 287–296. doi: 10.
1042/BJ20100507 PMID: 21158741
Disulfide Bridge in SNAT2
PLOSONE | DOI:10.1371/journal.pone.0158319 June 29, 2016 14 / 16
39. Baird FE, Pinilla-Tenas JJ, Ogilvie WLJ, Ganapathy V, Hundal HS, Taylor PM. Evidence for allosteric
regulation of pH-sensitive System A (SNAT2) and System N (SNAT5) amino acid transporter activity
involving a conserved histidine residue. Biochem J. 2006; 397: 369–375. PMID: 16629640
40. Ennion SJ, Evans RJ. Conserved cysteine residues in the extracellular loop of the human P2X1 recep-
tor form disulfide bonds and are involved in receptor trafficking to the cell surface. Mol Pharmacol.
2002, 61: 303–311. PMID: 11809854
41. Wakabayashi K, Nakagawa H, Tamura A, Koshiba S, Hoshijima K, Komada M, et al. Intramolecular
disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC)
transporter ABCG2 protein. J Biol Chem. 2007; 282: 27841–27846. PMID: 17686774
42. Lambert G, Traebert M, Biber J, Murer H. Cleavage of disulfide bonds leads to inactivation and degra-
dation of the type IIa, but not type IIb sodium phosphate cotransporter expressed in Xenopus laevis
oocytes. J Membr Biol. 2000; 176: 143–149. PMID: 10926679
43. Dorn M, Weiwad M, Markwardt F, Laug L, Rudolph R, Brandsch M, et al. Identification of a disulfide
bridge essential for transport function of the human proton-coupled amino acid transporter hPAT1. J
Biol Chem. 2009; 284: 22123–22132. doi: 10.1074/jbc.M109.023713 PMID: 19549785
44. Calderón-Rivera A, Andrade A, Hernandez-Hernandez O, Gonzalez-Ramirez R, Sandoval A, Rivera
M, et al. Identification of a disulfide bridge essential for structure and function of the voltage-gated Ca2+
channel α2Δ-1 auxiliary subunit. Cell Calcium. 2012; 51: 22–30. doi: 10.1016/j.ceca.2011.10.002
PMID: 22054663
45. Henriksen U, Fog JU, Litman T, Gether U. Identification of intra- and intermolecular disulfide bridges in
the multidrug resistance transporter ABCG2. J Biol Chem. 2005; 280: 36926–36934. PMID: 16107343
46. Gagnon DG, Bissonnette P, Lapointe JY. Identification of a disulfide bridge linking the fourth and the
seventh extracellular loops of the Na+/glucose cotransporter. J Gen Physiol. 2006; 127: 145–158.
PMID: 16446504
47. Padmanabhan R, Gu S, Nicholson BJ, Jiang JX. Identification of a disulfide bridge important for trans-
port function of SNAT4 neutral amino acid transporter. PloS one. 2013; 8: e56792. doi: 10.1371/journal.
pone.0056792 PMID: 23451088
48. Lu J, Deutsch C. Pegylation: a method for assessing topological accessibilities in Kv1. Biochemistry.
2001; 40: 13288–13301. PMID: 11683639
49. Guo ZY, Chang CC, Lu X, Chen J, Li BL, Chang TY. The disulfide linkage and the free sulfhydryl acces-
sibility of acyl-coenzyme A: cholesterol acyltransferase 1 as studied by using mPEG5000-maleimide.
Biochemistry. 2005; 44: 6537–6546. PMID: 15850387
50. Wang Y, Toei M, Forgac M. Analysis of the membrane topology of transmembrane segments in the C-
terminal hydrophobic domain of the yeast vacuolar ATPase subunit a (Vph1p) by chemical modifica-
tion. J Biol Chem. 2008; 283: 20696–20702. doi: 10.1074/jbc.M803258200 PMID: 18508769
51. Shen BQ, Xu K, Liu L, Raab H, Bhakta S, Kenrick M, et al. Conjugation site modulates the in vivo stabil-
ity and therapeutic activity of antibody- drug conjugates. Nat Biotechnol. 2012; 30: 184–189. doi: 10.
1038/nbt.2108 PMID: 22267010
52. Mordoch SS, Granot D, Lebendiker M, Schuldiner S. Scanning cysteine accessibility of EmrE, an H+-
coupled multidrug transporter from Escherichia coli, reveals a hydrophobic pathway for solutes. J Biol
Chem. 1999; 274: 19480–19486. PMID: 10383465
53. Leonard SE, Carroll KS. Chemical 'omics' approaches for understanding protein cysteine oxidation in
biology. Curr Opin Chem Bio. 2011; l15: 88–102.
54. Yernool D, Boudker O, Jin Y. Structure of a glutamate transporter homologue from Pyrococcus hori-
koshii. Nature. 2004; 431: 811–818. PMID: 15483603
55. Palmada M, Centelles JJ. Excitatory amino acid neurotransmission. Pathways for metabolism, storage
and reuptake of glutamate in brain. Front Biosci. 1998; 3: d701–718. PMID: 9665875
56. Bröer S. The SLC38 family of sodium-amino acid co-transporters. Pflügers Arch. 2014; 46:, 155–172.
57. Chen R, Wei H, Hill ER, Chen L, Jiang L, et al. Direct evidence that two cysteines in the dopamine trans-
porter form a disulfide bond. Mol Cell Biochem. 2007; 298: 41–48. PMID: 17131045
58. Fukuda Y, Aguilar-Bryan L, Vaxillaire M, Dechaume A, Wang Y, Dean M, et al. Conserved intramolecu-
lar disulfide bond is critical to trafficking and fate of ATP-binding cassette (ABC) transporters ABCB6
and sulfonylurea receptor 1 (SUR1)/ABCC8. J Biol Chem. 2011; 286: 8481–8492. doi: 10.1074/jbc.
M110.174516 PMID: 21199866
59. Cook JV, Eidne KA. An intramolecular disulfide bond between conserved extracellular cysteines in the
gonadotropin- releasing hormone receptor is essential for binding and activation. Endocrinology. 1997;
138: 2800–2806. PMID: 9202220
60. Frändberg PA, Doufexis M, Kapas S, Chhanjlani V. Cysteine residues are involved in structure and
function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two
Disulfide Bridge in SNAT2
PLOSONE | DOI:10.1371/journal.pone.0158319 June 29, 2016 15 / 16
converts an agonist to antagonist. Biochem Biophys Res Commun. 2001; 281: 851–857. PMID:
11237737
61. Padmanabhan R, Gu S, Nicholson BJ, Jiang JX. Residue cysteine 232 is important for substrate trans-
port of neutral amino acid transporter, SNAT4. Int J BiochemMol Biol. 2012; 3: 374–383. PMID:
23301202
62. Taylor PM. Role of amino acid transporters in amino acid sensing. Am J Clin Nutr. 2014; 99: 223–230.
63. Evans K, Nasim Z, Brown J, Clapp E, Amin A, Yang B, et al. Inhibition of SNAT2 by metabolic acidosis
enhances proteolysis in skeletal muscle. J Am Soc Nephro. 2008; l19: 2119–2129.
64. Lee IP, Evans AK, Yang C, Works MG, Kumar V, Zurine DM.et al. Toxoplasma gondii is dependent on
glutamine and alters migratory profile of infected host bone marrow derived immune cells through
SNAT2 and CXCR4 pathways. PLoS One. 2014; 9: e109803. doi: 10.1371/journal.pone.0109803
PMID: 25299045
65. Messens J, Collet JF. Thiol-disulfide exchange in signaling: disulfide bonds as a switch. Antioxid Redox
Signal. 2013; 18: 1594–1596. doi: 10.1089/ars.2012.5156 PMID: 23330837
Disulfide Bridge in SNAT2
PLOSONE | DOI:10.1371/journal.pone.0158319 June 29, 2016 16 / 16
